Exagen Diagnostics Obtains $5,016,977 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=daa0ffd1-13de-40a6-b273-ca2663f43b30
Date
10/16/2013
Company Name
Exagen Diagnostics
Mailing Address
1261 Liberty Way Vista, CA 92081
Company Description
Exagen Diagnostics Inc. discovers, validates and commercializes small sets of genomic markers, providing prognostic reagents for commercial laboratory testing and for pharmaceutical use in clinical trials. In leading the development of a new class of prognostic testing options, Exagen is working to create panels of tests that define a new standard of accuracy and performance.
Website
http://www.exagen.com
Transaction Type
Venture Equity
Transaction Amount
$5,016,977
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed